42 results
Page 2 of 3
40-F
EX-99.1
o841ro76l1jjxgb2080
17 Mar 21
Annual report (Canada)
12:00am
SUPPL
fm23b1
11 Feb 21
Supplemental materials (foreign)
8:32am
6-K
EX-99.1
bz56nay4
16 Nov 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:59am
SUPPL
5vww9nux2s
16 Oct 20
Supplemental materials (foreign)
5:19pm
6-K
EX-99.1
eo17c
11 Aug 20
Management’s Discussion and Analysis of Financial Condition and Results of
12:00am
SUPPL
i1o ddy1v9i
31 Jul 20
Supplemental materials (foreign)
9:43pm
SUPPL
awhgkj8
13 Jul 20
Supplemental materials (foreign)
12:00am
F-10/A
n2iac18wp791v6 72glj
16 Jun 20
Registration of securities (Canada) (amended)
9:20pm
6-K
EX-99.1
llbpt6sa0bdrz1
16 Jun 20
Material Change Report
12:00am
6-K
EX-99.1
chnanpasfd6r 8slx
3 Jun 20
FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
10:41am
6-K
EX-99.1
eo67ag
15 May 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:48am
40-F
EX-99.1
00hed02l08hv6p c4vb
4 Mar 20
Annual report (Canada)
12:29pm
40-F
EX-99.4
e67t6g3aigh36e6v3
4 Mar 20
Annual report (Canada)
12:29pm
F-10
zrawue
28 Feb 20
Registration of securities (Canada)
4:51pm
40FR12B
EX-99.47
ttl gegikrqt
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.32
kv02v
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.41
p8mx4xoa7
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.43
grqo ytjb
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.39
p2lkjlhizre6tztyxhh
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.35
p4mtdgrg 6t
6 Dec 19
Initial registration of securities (Canada)
12:28pm